Aconitum carmichaelii Debx. Attenuates Heart Failure through Inhibiting Inflammation and Abnormal Vascular Remodeling
Ziwei Xing1, Junren Chen1, Tingting Yu1
1State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Insights
A water extract of toasted Aconitum carmichaelii Debx. (WETA) protects against heart failure (HF) in rats by reducing inflammation and abnormal vascular remodeling. This traditional Chinese herb shows promise for treating myocardial infarction complications.
Area of Science:
- Cardiovascular Research
- Pharmacology
- Traditional Chinese Medicine
Background:
- Heart failure (HF) is a primary complication of myocardial infarction, linked to ventricular remodeling.
- Aconitum carmichaelii Debx. is a traditional Chinese herb with potential therapeutic effects on HF, but its mechanisms remain unclear.
Purpose of the Study:
- To investigate the protective effects and underlying mechanisms of a water extraction of toasted Aconitum carmichaelii Debx. (WETA) on isoproterenol (ISO)-induced heart failure in rats.
Main Methods:
- WETA was characterized using UPLC-Q/TOF-MS.
- Cardiac function and injury were assessed via echocardiography, serum markers (CK-MB, cTnT, cTnI), and tissue staining (TTC, H&E, Masson's trichrome).
- Inflammation and vascular remodeling markers were quantified using RT-qPCR, Western blot, and immunofluorescence.
Main Results:
- WETA significantly improved echocardiographic parameters and reduced heart weight, infarct size, myonecrosis, edema, and collagen deposition in ISO-induced HF rats.
- WETA lowered elevated serum levels of cardiac injury markers (CK-MB, cTnT, cTnI).
- WETA suppressed inflammatory gene expression (IL-1β, IL-6, TNF-α) and vascular remodeling markers (VCAM1, ICAM1, ANP, BNP, MHC) in heart tissues.
Conclusions:
- WETA demonstrates significant myocardial protective effects in ISO-treated rats.
- These protective effects are attributed to the inhibition of inflammatory responses and abnormal vascular remodeling.
- WETA holds potential as a therapeutic agent for HF associated with myocardial infarction.
Abstract:
Heart failure (HF) is the most common complication following myocardial infarction, closely associated with ventricular remodeling. Aconitum carmichaelii Debx., a traditional Chinese herb, possesses therapeutic effects on HF and related cardiac diseases. However, its effects and mechanisms on HF-associated cardiac diseases are still unclear. In the present study, a water extraction of toasted Aconitum carmichaelii Debx. (WETA) was verified using UPLC-Q/TOF-MS. The heart function of HF rats was assessed by echocardiography and strain analysis, and myocardial injury was measured by serum levels of CK-MB, cTnT, and cTnI. The pathological changes of cardiac tissues were evaluated by 2,3,5-triphenyltetrazolium chloride (TTC) staining, hematoxylin and eosin (H&E) staining, and Masson's trichrome staining. Additionally, the levels of inflammation-related genes and proteins and components related to vascular remodeling were detected by RT-qPCR, Western blot, and immunofluorescence. WETA significantly inhibited the changes in echocardiographic parameters and the increase in heart weight, cardiac infarction size, the myonecrosis, edema, and infiltration of inflammatory cells, collagen deposition in heart tissues, and also mitigated the elevated serum levels of CK-MB, cTnT, and cTnI in ISO-induced rats. Additionally, WETA suppressed the expressions of inflammatory genes, including IL-1β, IL-6, and TNF-α and vascular injury-related genes, such as VCAM1, ICAM1, ANP, BNP, and MHC in heart tissues of ISO-induced HF rats, which were further confirmed by Western blotting and immunofluorescence. In summary, the myocardial protective effect of WETA was conferred through inhibiting inflammatory responses and abnormal vascular remodeling in ISO-treated rats.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: Diuretics
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: Inotropic Agents


